Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 2.02% is 20% below its 5-year average of 2.52%, near the low end of its 5-year range (0.00%–141.26%).
As of the fiscal period ended Tuesday, June 30, 2026. 22.46% below its 12-month average of 2.60%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.02%.
DEBT TO ASSETS RATIO
2.02%
DEBT TO ASSETS RATIO AVG TTM
2.60%
DEBT TO ASSETS RATIO AVG 3Y
2.50%
DEBT TO ASSETS RATIO AVG 5Y
2.52%
DEBT TO ASSETS RATIO AVG 10Y
85.36%
DEBT TO ASSETS RATIO AVG 15Y
98.59%
DEBT TO ASSETS RATIO AVG 20Y
92.64%
CURRENT VS TTM AVG
-22.46%
CURRENT VS 3Y AVG
-19.18%
CURRENT VS 5Y AVG
-19.87%
CURRENT VS 10Y AVG
-97.64%
CURRENT VS 15Y AVG
-97.95%
CURRENT VS 20Y AVG
-97.82%
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+2140.99%
vs the sector median at left
Sunshine Biopharma, Inc.
Market Cap
$946332.00
Debt to Assets Ratio
2.02%
TTM Avg
2.60%
3Y Avg
2.50%
5Y Avg
2.52%
Market Cap
$901902.00
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.01M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$868077.00
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$827875.00
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$824550.00
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.08M
Debt to Assets Ratio
0.11%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.11M
Debt to Assets Ratio
0.10%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sunshine Biopharma, Inc. (SBFM) | $946332.00 | 2.02% | 2.60% | 2.50% | 2.52% |
| GlucoTrack, Inc. (GCTK)vs › | $901902.00 | 0.01% | N/A | N/A | N/A |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.01M | 0.00% | N/A | N/A | N/A |
| Bone Biologics Corporation (BBLG)vs › | $868077.00 | 0.00% | N/A | N/A | N/A |
| Ridgetech, Inc. (RDGT)vs › | $835994.00 | 0.00% | N/A | N/A | N/A |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $827875.00 | 0.01% | N/A | N/A | N/A |
| Decoy Therapeutics Inc. (DCOY)vs › | $824550.00 | 0.00% | N/A | N/A | N/A |
| Clearmind Medicine Inc. (CMND)vs › | $1.08M | 0.11% | N/A | N/A | N/A |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.11M | 0.10% | N/A | N/A | N/A |
| Propanc Biopharma, Inc. (PPCB)vs › | $1.12M | 0.04% | N/A | N/A | N/A |
Debt/Assets
2.0%
Debt/Equity
0.02
Current Ratio
5.46
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 2.02% |
| 2026-03-31 | 2.67% |
| 2025-12-31 | 2.70% |
| 2025-09-30 | 2.71% |
| 2025-06-30 | 2.91% |
| 2025-03-31 | 3.21% |
| 2024-12-31 | 3.12% |
| 2024-09-30 | 1.85% |
| 2024-06-30 | 1.97% |
| 2024-03-31 | 1.92% |
| 2023-12-31 | 2.41% |
| 2023-09-30 | 2.44% |
| 2023-06-30 | 2.53% |
| 2023-03-31 | 2.72% |
| 2022-12-31 | 2.59% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 86.25% |
| 2021-09-30 | 141.26% |
| 2021-06-30 | 139.12% |
| 2021-03-31 | 147.58% |
| 2020-12-31 | 182.99% |
| 2020-09-30 | 184.56% |
| 2020-06-30 | 396.21% |
| 2020-03-31 | 1007.55% |
| 2019-12-31 | 729.11% |
| 2019-09-30 | 513.66% |
| 2019-06-30 | 711.94% |
| 2019-03-31 | 99.41% |
| 2018-12-31 | 83.08% |
| 2018-09-30 | 82.45% |
| 2018-06-30 | 108.78% |
| 2018-03-31 | 136.46% |
| 2017-12-31 | 311.60% |
| 2017-09-30 | 231.15% |
| 2017-06-30 | 246.14% |
| 2017-03-31 | 1090.73% |
| 2016-12-31 | 367.94% |
| 2016-09-30 | 41.55% |
| 2016-06-30 | 48.71% |
| 2016-03-31 | 132.98% |
| 2015-12-31 | 169.41% |
| 2015-09-30 | 306.39% |
| 2015-06-30 | 228.78% |
| 2015-03-31 | 210.58% |
| 2014-12-31 | 334.76% |
| 2014-09-30 | 219.66% |
| 2014-06-30 | 641.30% |
| 2014-03-31 | 184.53% |
| 2013-12-31 | 40.01% |
| 2013-09-30 | 17.46% |
| 2013-06-30 | 7.77% |
| 2013-03-31 | 4.83% |
| 2012-12-31 | 46.37% |
| 2012-09-30 | 4.66% |
| 2012-06-30 | 11.47% |
| 2012-03-31 | 14.85% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-10-31 | 0.00% |
| 2009-07-31 | 4866.56% |
| 2009-04-30 | 4166.67% |
| 2009-01-31 | 1788.62% |
| 2008-10-31 | 920.12% |
| 2008-07-31 | 338.04% |
| 2008-04-30 | 255.15% |
| 2008-01-31 | 0.00% |
| 2007-10-31 | 0.00% |
